Literature DB >> 27066123

Respiratory physiology of pregnancy: Physiology masterclass.

Antonella LoMauro1, Andrea Aliverti1.   

Abstract

Physiology masterclass: respiratory physiology of pregnancy http://ow.ly/UvYXt.

Entities:  

Year:  2015        PMID: 27066123      PMCID: PMC4818213          DOI: 10.1183/20734735.008615

Source DB:  PubMed          Journal:  Breathe (Sheff)        ISSN: 1810-6838


During healthy pregnancy, pulmonary function, ventilatory pattern and gas exchange are affected through both biochemical and mechanical pathways, as summarised in figure 1.
Figure 1

Flow diagram summarising the most important effects of biochemical (left) and mechanical (right) pregnancy-induced factors on pulmonary function, ventilatory pattern and gas exchange. PO: oxygen tension; PCO: carbon dioxide tension; FRC: functional residual capacity; ERV: expiratory reserve volume; TLC: total lung capacity; IC: inspiratory capacity; VC: vital capacity; ↑: increased; ↓: decreased; ≈: no change.

Flow diagram summarising the most important effects of biochemical (left) and mechanical (right) pregnancy-induced factors on pulmonary function, ventilatory pattern and gas exchange. PO: oxygen tension; PCO: carbon dioxide tension; FRC: functional residual capacity; ERV: expiratory reserve volume; TLC: total lung capacity; IC: inspiratory capacity; VC: vital capacity; ↑: increased; ↓: decreased; ≈: no change.

Chemical/hormonal changes

During pregnancy, the physiological alteration of hormonal patterns is the main cause of ventilatory changes in respiratory function.

Progesterone

Progesterone gradually increases during the course of pregnancy, from 25 ng⋅mL−1 at 6 weeks’ to 150 ng⋅mL−1 at 37 weeks’ gestation [1-5]. Progesterone acts as trigger of the primary respiratory centre by increasing the sensitivity of the respiratory centre to carbon dioxide, as indicated by the steeper slope of the ventilation curve in response to alveolar carbon dioxide changes [6]. Progesterone alters the smooth muscle tone of the airways resulting in a bronchodilator effect. It also mediates hyperaemia and oedema of mucosal surfaces, causing nasal congestion.

Oestrogen

The circulating levels of oestrogen increase during pregnancy, before or in parallel to those of progesterone. Oestrogen is a mediator of progesterone receptors. It increases the number and the sensitivity of progesterone receptors within the hypothalamus and medulla, the central neuronal respiratory-related areas [1].

Prostaglandins

Prostaglandins stimulate uterine smooth muscle during labour and are present during all three trimesters of pregnancy. Prostaglandin F2α increases airway resistance by bronchial smooth muscle constriction, whereas a bronchodilator effect can be a consequence of prostaglandins E1 and E2 [1].

Mechanical effects

The progressive uterine distension is the major cause of lung volume and chest wall changes during pregnancy, which comprise elevation of the diaphragm and altered thoracic configuration [1-3]. The enlarging uterus increases the end-expiratory abdominal (gastric) pressure (Pga), thereby displacing the diaphragm upwards, with two consequences [2]. First, the negative pleural pressure (oesophageal pressure (Poes)) increases, leading to an earlier closure of the small airways with consequent reduction of functional residual capacity (FRC) and expiratory reserve volume (ERV) [1, 3, 4, 7]. Secondly, the chest height becomes shorter, but the other thoracic dimensions increase in order to maintain constant total lung capacity (TLC) [1, 2, 7].

Lung volumes, spirometry and airway function

Throughout pregnancy, spirometry remains within normal limits, with forced vital capacity (FVC) [1, 3–5, 7–9], forced expiratory volume in 1 s (FEV1) [1, 4, 5, 7, 9] and peak expiratory flow [4, 7–9] not changing or modestly increasing with unaltered FEV1/FVC index [1, 4, 5, 7, 9]. Conversely, lung volumes undergo major changes: ERV gradually decreases during the second half of pregnancy (reduction of 8–40% at term) because residual volume reduces (by 7–22%). FRC then decreases (by 9.5–25%) while inspiratory capacity increases at the same rate in order to maintain stable TLC [1, 3, 4, 7]. Respiratory resistance increases while respiratory conductance decreases during pregnancy. Total pulmonary and airways resistances tend to decrease in late pregnancy as a consequence of hormonally induced relaxation of tracheobronchial tree smooth muscles [1, 4, 8]. Pulmonary static and dynamic compliance, diffusing capacity and static lung recoil pressure do not change during pregnancy [1, 2, 4, 7]. Respiratory function does not differ between singleton and twin pregnancies [7].

Chest wall geometry and displacement

The pregnancy-induced reduction of FRC is accompanied not only by abdominal enlargement but also by ribcage dimension increases. The ribcage expands, as its transversal diameter and the lower thoracic perimeter increase in the third trimester compared with postpartum. The average subcostal angle of the ribs at the xiphoidal level increases from 68.5° at the beginning of pregnancy to 103.5° at term [1-3]. Such ribcage dimension changes could be a consequence of fatty tissue and fluid accumulation, particularly blood, since pulmonary blood volume is often increased in pregnancy. However, it seems more likely to be a compensation of the shortening of the thorax due to the upward movement of the diaphragm, in order to guarantee space to the lung and preserve TLC. Chest wall compliance decreases in late pregnancy due to the increased abdominal content [10].

Breathing pattern at rest

Minute ventilation (V′E) starts to increase significantly (by up to 48%) during the first trimester of gestation, due to higher tidal volume (VT) with unchanged respiratory rate. This ventilatory pattern is then maintained throughout the course of pregnancy [1–3, 5, 8]. Both VT/inspiratory time ratio and mouth occlusion pressure at 100 ms increase during pregnancy, indicating respectively that the ventilatory and inspiratory drives augment [2, 8]. The increased VT in pregnancy is achieved mainly by an improved displacement of the ribcage with no consistent changes in the abdominal contribution measured with magnetometers [2, 3].

Respiratory muscles

Maximal inspiratory and expiratory pressures do not change during pregnancy or after delivery indicating that, although there is alteration of chest wall geometry, the respiratory muscle strength is preserved [2–4, 11]. With pregnancy progression, the resting position of the diaphragm moves 5 cm upward with the increasing uterus size, as shown by chest radiograph measurement [1, 2, 12]. This causes the following changes to the diaphragm: its capability to generate tension increases secondary to muscle fibre lengthening; its area of apposition to the lower ribcage increases; and its radius of curvature increases, due to the progressive enlargement of the lower ribcage to give space to the lungs. In addition, the upward movement of the diaphragm causes FRC decrease. The inspiratory movements of the diaphragm are similar or become even broader than postpartum [1, 12], and trans-diaphragmatic pressure swings during tidal breathing do not change [2]. The diaphragmatic work may increase as a consequence to contract against higher load represented by higher end-expiratory Pga and enlarged gravid uterus. This hypothesis is supported by the tension time index of the diaphragm, which falls after delivery [2]. During pregnancy, chest wall expansion is shifted toward the ribcage because of an enhanced coupling between abdominal pressure and the lower ribcage [2, 3]. Thanks to the increased area of apposition, in fact, the abdominal pressure generated by the contraction of the diaphragm acts mainly on the lower ribs, thereby elevating and expanding the ribcage where the diaphragm is apposed. Two possible respiratory muscle strategies can be considered during pregnancy. 1) Higher inspiratory intercostal and accessory muscle recruitment, since the increased thoracic volume displacement and pleural pressure swings could also be a consequence of their enhanced action [2, 3]. 2) Similar relative contribution between the diaphragm and the inspiratory intercostal muscles, since the slope of the Pga versus Poes curve remains constant [2, 3]. The progressive increment of the anterior abdominal dimension leads to morphological adaptation of the abdominal muscles by lengthening their fibres up to 115%, changing their line of action, altering their angle of insertion and reducing their thickness. The consequences are compromised functional ability, poor torque production and reduced ability to stabilise the pelvis against resistance. The latter may be implicated in back pain during pregnancy [13, 14].

Oxygen consumption, arterial blood gases and acid–base status

Oxygen consumption and basal metabolic rate increase (by up to 21% and 14%, respectively), but to a lesser extent than ventilatory augmentation [1, 5]. Pregnancy-induced reduction in FRC combined with a rise in oxygen consumption lowers the oxygen reserve of the mother. As a consequence of V′E increment, alveolar and arterial carbon dioxide tension (PCO) levels decrease to plateaux around 27 and 32 mmHg, respectively [1, 4, 5]. During labour, arterial PCO further decreases with each contraction, while at full dilatation it decreases even between contractions [1]. Following hyperventilation and reduced levels of PCO, arterial oxygen tension increases, reaching 106–108 mmHg and 101–104 mmHg in the first and third trimesters, respectively [1]. Despite hyperventilation and respiratory alkalosis, blood pH remains almost constant at slightly alkalotic values (7.40–7.47), thanks to renal compensation by increasing the excretion of bicarbonate [1, 4, 5].

Dyspnoea

Dyspnoea or breathlessness is commonly reported by 70% of healthy pregnant women during their daily living activities, starting from the very first trimester of gestation. Such an early time of onset excludes the pregnancy-induced mechanical changes from playing a role in the genesis of the symptoms [1]. Possible explanations could be: 1) an increased awareness of the new sensation of the physiological hyperventilation associated with pregnancy; 2) an increased central perception of respiratory discomfort with increasing V′E; or 3) a combination of these two. Recently, pregnancy-induced hyperventilation has been demonstrated to be the result of complex interactions between changes in chemo-reflex drives, acid–base balance, metabolic rate and cerebral blood flow [5]. It is therefore a difficult challenge for the caregiver to distinguish between physiological and pathophysiological origins of dyspnoea.

Exercise

Pregnant women preserve their aerobic working capacity even in late gestation. The physiological response to incremental exercise in healthy pregnant women consists of augmentation of both V′E and oxygen consumption, with higher ventilatory equivalent (i.e. V′E/oxygen consumption) [1, 4]. Hyperventilation occurs thanks to the recruitment of resting inspiratory capacity combined with pregnancy-induced bronchodilation, allowing VT to increase in order to meet the metabolic demands. Inspiratory capacity is recruited thanks to stable TLC and pre-exercise end-expiratory lung volume reduction. Because ERV is reduced, end-expiratory lung volume does not further decrease during exercise to avoid the mechanical disadvantage of the lower portion of the pressure–volume curve of the respiratory system. The ratio of the contractile effort of the respiratory muscles (tidal Poes/maximal inspiratory Poes) to the thoracic volume displacement (VT/vital capacity), being an index of neuromechanical (un)coupling of the respiratory system, does not change with increasing exercise. Pregnancy therefore does not influence the symptom-limited perceptual reasons to stop exercise and the increased breathlessness is a normal consequence of the increment of both V′E and work of breathing [4].

Pregnancy during disease

In addition to the biochemical and mechanical factors, many illnesses produce significant negative effects on respiratory maternal (and fetal) outcomes. Table 1 summarises the principal features to consider when treating unhealthy pregnant women.
Table 1

Principal features to consider when treating unhealthy pregnant women

DiseaseFeatures and/or indications
Asthma [15]Recommended use of corticosteroids to prevent critical illness
Oral corticosteroids associated with a two-fold increase in pre-eclampsia and with a minimal incidence (0.4%) +of oral clefts (if taken in the first trimester)
Pulmonary oedema [15]Cardiogenic basis secondary to haemodynamic factors occurring during pregnancy:
 ↑ cardiac output
 ↑ heart rate
 ↓ systemic vascular resistance
 ↓ colloid osmotic pressure
A consequence of tocolytic therapy and of pre-eclampsia
If no improvement within 24 h after diuresis, invasive haemodynamic monitoring and/or rapid antihypertensive therapy are required
Severe restrictive lung disease [10]Risk of hypoxic and hypercapnic respiratory failure because the ability to increase ventilation is limited
Severely reduced vital capacity but pregnancy can be well tolerated
Minimal complication: preterm delivery with newborn needing high-dependency support
Lung function and oxygen saturation should be monitored
Supplemental oxygen and noninvasive ventilation may be required
Pre-eclampsia [16]The most common obstetric disorder, with multisystem ramifications
↑ minute ventilation because of ↑ concentration of blood leptin (a ventilation-stimulating hormone)
↓ vital capacity secondary to lower transverse section area of the upper airways, pharyngeal oedema and excessive weight gain with higher adipose deposition around the neck
↓ exercise tolerance
Respiratory muscle function is not affected
Heart and lung transplantation [17]Better to avoid conception within the first 1–2 years after transplantation
Potential pregnancy-related complications: prematurity, low weight at birth and postpartum graft loss
Maintenance of immunosuppression with close monitoring of cyclosporine blood levels during gestation
Accurately diagnose signs of pre-eclampsia, as it is a multi-organ disease
Hereditary neuromuscular disorders [18]Identify the highest risk group according to the diaphragmatic and/or bulbar involvement of the disease
↑ respiratory muscle load by higher airway resistance and impaired bulbar load, leading to overwhelmed respiratory muscle capacity
Hypoventilation
Monitor the respiratory and cough function
Maximise airway clearance
High aspiration risk in the third trimester because of ↑ abdominal pressure and ↓ gastro-oesophageal sphincter tone
ARDS [19]Non-obstetric causes: sepsis, pneumonia, intracerebral haemorrhage, blood transfusion and trauma
Obstetric causes: amniotic fluid embolism, pre-eclampsia, septic abortion, retained products of conception and complication from tocolytic therapy
Management includes: prompt antibiotic therapy, conservative fluid strategy, use of mechanical ventilation and extracorporeal life support in case of refractory ARDS
Mechanical ventilation [20]Similar indications to those for non-pregnant patients, with some exceptions:
 Oxygen therapy may also help fetal distress
 Consider that PCO2 in pregnancy is about 30 mmHg when interpreting arterial blood gases
 Airways are narrow (consequence of mucosal surface hyperaemia), so it is preferable to perform endotracheal intubation via oral route using a smaller tube
  ↓ oxygen reserve of the mother, so use pre-oxygenation with 100% oxygen during intubation to avoid arterial desaturation after a short period of apnoea
 Better to avoid respiratory alkalosis as it leads to problems in uterine blood flow and fetal oxygenation
 Treat respiratory acidosis with bicarbonate

ARDS: acute respiratory distress syndrome; ↑: increased; ↓: decreased.

Principal features to consider when treating unhealthy pregnant women ARDS: acute respiratory distress syndrome; ↑: increased; ↓: decreased.
  18 in total

Review 1.  Implications for the pregnant patient.

Authors:  L A Campbell; R A Klocke
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

2.  Respiratory muscle strength in pregnancy.

Authors:  Andrea Lemos; Ariani Impieri de Souza; José Natal Figueiroa; José Eulálio Cabral-Filho; Armele Dornelas de Andrade
Journal:  Respir Med       Date:  2010-06-23       Impact factor: 3.415

Review 3.  ARDS in pregnancy.

Authors:  Alexander G Duarte
Journal:  Clin Obstet Gynecol       Date:  2014-12       Impact factor: 2.190

4.  Changes in pulmonary function during pregnancy: a longitudinal cohort study.

Authors:  G Grindheim; K Toska; M-E Estensen; L A Rosseland
Journal:  BJOG       Date:  2011-10-18       Impact factor: 6.531

5.  Ventilatory drive and respiratory muscle function in pregnancy.

Authors:  G Contreras; M Gutiérrez; T Beroíza; A Fantín; H Oddó; L Villarroel; E Cruz; C Lisboa
Journal:  Am Rev Respir Dis       Date:  1991-10

6.  179th ENMC international workshop: pregnancy in women with neuromuscular disorders 5-7 November 2010, Naarden, The Netherlands.

Authors:  Fiona Norwood; Sabine Rudnik-Schöneborn
Journal:  Neuromuscul Disord       Date:  2011-07-13       Impact factor: 4.296

7.  Rib cage and abdominal volume displacements during breathing in pregnancy.

Authors:  R J Gilroy; B T Mangura; M H Lavietes
Journal:  Am Rev Respir Dis       Date:  1988-03

8.  Ultrasound Assessment of Abdominal Muscle Thickness in Postpartum vs Nulliparous Women.

Authors:  Carol Ann Weis; John J Triano; Jon Barrett; Michelle D Campbell; Martine Croy; Jessica Roeder
Journal:  J Manipulative Physiol Ther       Date:  2015-06       Impact factor: 1.437

9.  Physiological mechanisms of hyperventilation during human pregnancy.

Authors:  Dennis Jensen; James Duffin; Yuk-Miu Lam; Katherine A Webb; Jeremy A Simpson; Gregory A L Davies; Larry A Wolfe; Denis E O'Donnell
Journal:  Respir Physiol Neurobiol       Date:  2008-01-12       Impact factor: 1.931

10.  Mechanical ventilatory constraints during incremental cycle exercise in human pregnancy: implications for respiratory sensation.

Authors:  Dennis Jensen; Katherine A Webb; Gregory A L Davies; Denis E O'Donnell
Journal:  J Physiol       Date:  2008-08-07       Impact factor: 5.182

View more
  48 in total

Review 1.  Endocrine regulation of lung disease and inflammation.

Authors:  Nathalie Fuentes; Patricia Silveyra
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-03

Review 2.  [Physiological changes during pregnancy].

Authors:  L M Kohlhepp; G Hollerich; L Vo; K Hofmann-Kiefer; M Rehm; F Louwen; K Zacharowski; C F Weber
Journal:  Anaesthesist       Date:  2018-05       Impact factor: 1.041

Review 3.  Critical Care in Obstetrics: Where are We.

Authors:  Sushil Chawla; T Jose; Manish Paul
Journal:  J Obstet Gynaecol India       Date:  2018-03-26

4.  Pregnancy preserves pulmonary function following influenza virus infection in C57BL/6 mice.

Authors:  Meghan S Vermillion; Andrew Nelson; Landon Vom Steeg; Jeffery Loube; Wayne Mitzner; Sabra L Klein
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-05-31       Impact factor: 5.464

Review 5.  Anatomical and physiological alterations of pregnancy.

Authors:  Jamil M Kazma; John van den Anker; Karel Allegaert; André Dallmann; Homa K Ahmadzia
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-06       Impact factor: 2.745

6.  Anesthetic Management of the Pregnant Patient: Part 1.

Authors:  Jaimin Shin
Journal:  Anesth Prog       Date:  2021-03-01

Review 7.  Asthma Outcomes and Management During Pregnancy.

Authors:  Catherine A Bonham; Karen C Patterson; Mary E Strek
Journal:  Chest       Date:  2017-09-01       Impact factor: 9.410

8.  Asthma in Pregnancy. Review of Current Literature and Recommendations.

Authors:  Maria Popa; Gheorghe Peltecu; Nicolae Gica; Anca Marina Ciobanu; Radu Botezatu; Corina Gica; Alexandru Steriade; Anca Maria Panaitescu
Journal:  Maedica (Bucur)       Date:  2021-03

9.  Perinatal Hypoxemia and Oxygen Sensing.

Authors:  Gary C Mouradian; Satyan Lakshminrusimha; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

10.  High prevalence of obstructive sleep apnea in pregnant women with class III obesity: a prospective cohort study.

Authors:  Emma C Johns; Elizabeth A Hill; Stevie Williams; AbdelKebir Sabil; Renata L Riha; Fiona C Denison; Rebecca M Reynolds
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.